H1 sales of CHF5.59 billion were about 3% above consensus; implied Q2 local-currency growth of 6.8% and organic growth of 5.7% were far above expectations of roughly 1.7% and 0.6%. EBITDA of CHF1.06 billion beat consensus by about 4%, and the 19.0% margin was roughly 20 basis points ahead despite cost inflation. Management raised local-currency sales growth to 3–6% from 1–4% but cut the EBITDA-margin range to 19.0–19.5% from 19.5–20.0%.
[AS-024]The sales range increased by two percentage points at both ends, the margin range fell by 50 basis points, and management said it was comfortable with absolute EBITDA consensus around CHF2.16 billion. Fast Forward savings remained on track and MBCC integration was declared complete.
[AS-024]The sales range implies roughly 2%, 5% or 8% local-currency growth in H2 at the low end, midpoint and high end. The margin range implies an H2 margin near 19%, 19.5% or 20%, versus 19.0% in H1 and roughly 18% in H2 2025.
[AS-024]A completed closing-price reaction was not yet available. The setup pits a much stronger organic-sales trajectory and protected CHF EBITDA against the optical margin cut and evidence that price is doing more work than volume.
[MKT-001]H1 sales of CHF5.59 billion were about 3% above consensus; implied Q2 local-currency growth of 6.8% and organic growth of 5.7% were far above expectations of roughly 1.7% and 0.6%. EBITDA of CHF1.06 billion beat consensus by about 4%, and the 19.0% margin was roughly 20 basis points ahead despite cost inflation. Management raised local-currency sales growth to 3–6% from 1–4% but cut the EBITDA-margin range to 19.0–19.5% from 19.5–20.0%.
H1 sales of CHF5.59 billion were about 3% above consensus; implied Q2 local-currency growth of 6.8% and organic growth of 5.7% were far above expectations of roughly 1.7% and 0.6%.
EBITDA of CHF1.06 billion beat consensus by about 4%, and the 19.0% margin was roughly 20 basis points ahead despite cost inflation.
Management raised local-currency sales growth to 3–6% from 1–4% but cut the EBITDA-margin range to 19.0–19.5% from 19.5–20.0%.
The sales range increased by two percentage points at both ends, the margin range fell by 50 basis points, and management said it was comfortable with absolute EBITDA consensus around CHF2.16 billion. Fast Forward savings remained on track and MBCC integration was declared complete.
| Metric | Prior | Latest | Delta | Status | Implication |
|---|---|---|---|---|---|
| Sales growth in local currencies | 1–4% | 3–6% | +2pp at both ends | Raised | About 2% / 5% / 8% in H2 at low / midpoint / high |
| EBITDA margin | 19.5–20.0% | 19.0–19.5% | -50bp at both ends | Lowered | About 19.0% / 19.5% / 20.0% in H2 at low / midpoint / high |
| Absolute EBITDA | Not formally guided | Comfortable with Street near CHF2.16B | Directional confirmation | Broadly protected | Roughly CHF2.14–2.26B using sales and margin endpoints |
| Fast Forward savings | CHF80M in 2026 | CHF80M in 2026 | No change | On track | Savings remain an H2 margin and EBITDA offset |
| MBCC synergies | CHF200–220M run-rate targeted by end-2026 | CHF182M realized; integration complete | Program moved from target to realized exit phase | Integration complete | Most identified integration value is already in the run rate |
| Acquisition contribution | Akkim expected to close during 2026 | Akkim expected to close in Q3 | Timing narrowed | Pending close | Partial-year contribution from approximately CHF220M of acquired sales |
The direct read-through was to organic growth, the volume contribution, price realization and material margin. The key question shifted from demand survival to the quality of the growth mix.
The sales range implies roughly 2%, 5% or 8% local-currency growth in H2 at the low end, midpoint and high end. The margin range implies an H2 margin near 19%, 19.5% or 20%, versus 19.0% in H1 and roughly 18% in H2 2025.
A completed closing-price reaction was not yet available. The setup pits a much stronger organic-sales trajectory and protected CHF EBITDA against the optical margin cut and evidence that price is doing more work than volume.
The shares gained 9.8% on the first completed post-results session; two- and five-session windows were not yet available at the cutoff.
| Window | Stock | vs benchmark | vs peers |
|---|---|---|---|
| 1D | +9.8% | +8.7% | +8.4% |
| 2D | N/A | N/A | N/A |
| 5D | N/A | N/A | N/A |
The story broadened from price-led defense to an early volume recovery, even as input and freight costs began to rise.
H1 included positive volume growth, Q2 volume improved further and Middle East activity rebounded; the US and China still required confirmation.
The acute Middle East disruption became manageable, but raw-material and logistics inflation started to enter the P&L.
Sika's ability to recover freight and input costs without losing share became the relevant competitive indicator; regional growth remained uneven.
Only the first post-results closing session was available at the 28 July cutoff. No full management transcript was available.
AlphaSense synthesis
Open source ↗Official company source
Open source ↗AlphaSense market-environment synthesis
Open source ↗